(Q51316112)

3 April 2018

title

Twice-daily dapagliflozin co-administered with metformin in type 2 diabetes: a 16-week randomized, placebo-controlled clinical trial. (English)

1 reference

3 April 2018

0 references

1 reference

ChEBI release 2020-05-28

1 reference

1 reference

P-M Schumm-Draeger

1

1 reference

3 April 2018

L Burgess

2

1 reference

3 April 2018

L Korányi

3

1 reference

3 April 2018

V Hruba

4

1 reference

3 April 2018

J E Hamer-Maansson

5

1 reference

3 April 2018

T W A de Bruin

6

1 reference

3 April 2018

publication date

16 October 2014

1 reference

3 April 2018

Diabetes, Obesity and Metabolism

published in

1 reference

3 April 2018

volume

17

1 reference

3 April 2018

issue

1

1 reference

3 April 2018

page(s)

42-51

1 reference

3 April 2018

Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).

cites work

1 reference

Standards of medical care in diabetes--2013

21 January 2018

1 reference

United Kingdom Prospective Diabetes Study 17: a 9-year update of a randomized, controlled trial on the effect of improved metabolic control on complications in non-insulin-dependent diabetes mellitus.

21 January 2018

1 reference

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study

21 January 2018

1 reference

Effect of dapagliflozin in patients with type 2 diabetes who have inadequate glycaemic control with metformin: a randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

Dapagliflozin, metformin XR, or both: initial pharmacotherapy for type 2 diabetes, a randomised controlled trial

21 January 2018

1 reference

Dapagliflozin versus glipizide as add-on therapy in patients with type 2 diabetes who have inadequate glycemic control with metformin: a randomized, 52-week, double-blind, active-controlled noninferiority trial

21 January 2018

1 reference

Glucose transporters in human renal proximal tubular cells isolated from the urine of patients with non-insulin-dependent diabetes

21 January 2018

1 reference

Dapagliflozin, a novel, selective SGLT2 inhibitor, improved glycemic control over 2 weeks in patients with type 2 diabetes mellitus

21 January 2018

1 reference

Dapagliflozin monotherapy in type 2 diabetic patients with inadequate glycemic control by diet and exercise: a randomized, double-blind, placebo-controlled, phase 3 trial

21 January 2018

1 reference

Sodium-glucose cotransport inhibition with dapagliflozin in type 2 diabetes

21 January 2018

1 reference

Effects of dapagliflozin, an SGLT2 inhibitor, on HbA(1c), body weight, and hypoglycemia risk in patients with type 2 diabetes inadequately controlled on pioglitazone monotherapy

21 January 2018

1 reference

Effect of dapagliflozin in patients with type 2 diabetes who have inadequate glycaemic control with glimepiride: a randomized, 24-week, double-blind, placebo-controlled trial.

21 January 2018

1 reference

Long-term efficacy of dapagliflozin in patients with type 2 diabetes mellitus receiving high doses of insulin: a randomized trial.

21 January 2018

1 reference

Dapagliflozin add-on to metformin in type 2 diabetes inadequately controlled with metformin: a randomized, double-blind, placebo-controlled 102-week trial

21 January 2018

1 reference

Effects of dapagliflozin on body weight, total fat mass, and regional adipose tissue distribution in patients with type 2 diabetes mellitus with inadequate glycemic control on metformin

21 January 2018

1 reference

Efficacy of metformin in type II diabetes: results of a double-blind, placebo-controlled, dose-response trial.

21 January 2018

1 reference

Compliance with antihypertensive therapy in the elderly: a comparison of fixed-dose combination amlodipine/benazepril versus component-based free-combination therapy

21 January 2018

1 reference

A systematic review of the associations between dose regimens and medication compliance

21 January 2018

1 reference

Fixed-dose combinations improve medication compliance: a meta-analysis.

21 January 2018

1 reference

Adherence to oral antidiabetic therapy in a managed care organization: a comparison of monotherapy, combination therapy, and fixed-dose combination therapy

21 January 2018

1 reference

Effect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitus

21 January 2018

1 reference

Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes

21 January 2018

1 reference

A sharper Bonferroni procedure for multiple tests of significance

21 January 2018

1 reference

Improving efficiency of inferences in randomized clinical trials using auxiliary covariates

21 January 2018

1 reference

Covariate adjustment for two-sample treatment comparisons in randomized clinical trials: a principled yet flexible approach

21 January 2018

1 reference

Baseline glycemic parameters predict the hemoglobin A1c response to DPP-4 inhibitors : meta-regression analysis of 78 randomized controlled trials with 20,053 patients.

21 January 2018

1 reference

Lower baseline glycemia reduces apparent oral agent glucose-lowering efficacy: a meta-regression analysis

21 January 2018

1 reference

Relationship of baseline HbA1c and efficacy of current glucose-lowering therapies: a meta-analysis of randomized clinical trials

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/DOM.12387

1 reference

3 April 2018

1 reference

3 April 2018